
Biotech Bros
Agustin discusses the unique nature of biotech investing, finance & maximizing your returns all while having a good time. Follow me on Twitter @Biotech_Bros https://twitter.com/Biotech_Bros
Investing
Medicine
Business
Ensysce Biosciences: A Solution to the Opioid Crisis?
This week on the podcast Agustin sits down with the ...
more
Feb 6 2023 25m
CRL for Eli Lilly and Leap Therapeutics Searches for a Flame?
This week on the podcast Agustin discusses some new ...
more
Jan 24 2023 52m
Chapter 1 44 sec
[Ad] Dive deep into the motivations and mechanics behind some very successful people.Chapter 2 39 mins
(Cont.) CRL for Eli Lilly and Leap Therapeutics Searches for a Flame?
A Lackluster JPM and a Troubling future for Fate Therapeutics
This week on the podcast Agustin discusses the excit...
more
Jan 16 2023 56m
The Importance of Value Perception in Biotech with Samina Bari
This week on the podcast Agustin sits down with the ...
more
Jan 9 2023 39m
A Therapy for NASH, Another Alzheimer's Competitor, and Reflections on 2022
This week on the podcast Agustin discusses Madrigal ...
more
Jan 2 2023 1h 2m
Questions around the Tesla of Biotech, Amgen buying Horizon, and Mirati in the Dumps
This week on the podcast Agustin shares some recent ...
more
Dec 12 2022 1h
Setting the Record Straight with $LPTX and $AFMD
This week on the podcast Agustin provides updates on...
more
Nov 21 2022 1h 4m
PRIME Medicines Big IPO and an attractive play in the NASH space
This week on the podcast Agustin talks about the rec...
more
Nov 7 2022 57m
Behind the Scenes of an IPO: Interview with TC Biopharm
This week on the podcast Agustin sits down with the ...
more
Oct 17 2022 54m
A Potential Recession and Another Alzheimer's Drug from Biogen
This week on the podcast Agustin talks recent macroe...
more
Oct 11 2022 53m
Good News for $AMLX and Covid Booster Approvals with only Mouse Data?
This week on the podcast Agustin discusses news arou...
more
Sep 12 2022 53m
More Data for The Most Undervalued Biotech
This week on the podcast Agustin highlights the rece...
more
Aug 29 2022 45m
Things Looking Green for $XBI and Alnylam Pharmaceuticals
This week on the podcast Agustin addresses the flurr...
more
Aug 15 2022 56m
Aggressive Management for $LPTX and Fraud in Alzheimer's and $SAVA
This week on the podcast Agustin discusses Leap Ther...
more
Aug 1 2022 1h 3m
Acquisitions in the $XBI, a Second Chance at bat for $AMLX, and a Potential Cure for Huntington's
This week on the podcast Agustin discusses the recen...
more
Jul 18 2022 59m
More Issues for CRISPR Therapeutics: Another CAR-T Failure in Solid Tumors
This week on the podcast Agustin discusses the recen...
more
Jul 5 2022 45m
How to Navigate Biotech with Maxim Jacobs
This week on the podcast Agustin sits down with Maxi...
more
Jun 27 2022 57m
Major Win for GSK and Uncertainty for Infinity Pharmaceuticals
On this week's episode, Agustin discusses the r...
more
Jun 21 2022 1h 8m
The Failure of TIGIT Antibodies and the battle for KRAS Superiority
On this week's episode, Agustin discusses the f...
more
Jun 13 2022 39m
Sneak Peak into ASCO and Conflicting $PDSB Data
On this week's episode, Agustin shares some pre...
more
Jun 7 2022 40m
The Future of TechBio: One on One with Jeff Galvin of American Gene Technologies
This week on the podcast Agustin sits down with Jeff...
more
May 24 2022 1h 1m
One on One Interview with BioMark Diagnostics CEO
This week on the podcast Agustin sits down with Rash...
more
May 16 2022 48m
The Winners and Losers of AACR
On this week's episode, Agustin highlights the ...
more
Apr 25 2022 51m
Bad News for Moderna and Amylyx Pharmaceuticals
On this week's episode, Agustin addresses the u...
more
Apr 11 2022 45m
No Accelerated Approvals for You!
On this week's episode, Agustin shares his opin...
more
Mar 28 2022 42m